loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 20920 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    SCIOS LLC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NESIRITIDE RECOMBINANT (1)

    filter

    01 SCIOS LLC (1)

    filter

    01 FOR SOLUTION;INTRAVENOUS (1)

    filter

    01 1.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Nesiritide Recombinant

      PDF Supplier PDF
      URL Supplier Web Content
      FOR SOLUTION;INTRAVENO...
      1.5MG/VIAL **Federal R...
      NATRECOR
      USA
      20920
      2001-08-10
      DISCN
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 20920

      Looking for CTD TGA MCC DOSSIER APPLICATION 20920 1

      19

      SCIOS LLC, based in U.S.A, is a pharmaceutical company.

      One of their notable products is NESIRITIDE RECOMBINANT, with a corresponding application number 20920 and regulatory information .

      proudly manufactured in the

      approval since 2001-08-10

      SCIOS LLC's NATRECOR FOR SOLUTION;INTRAVENOUS, medication with 1.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NESIRITIDE RECOMBINANT.

      Post Enquiry
      POST ENQUIRY